Table 1 Characteristics of the patients included in the profiling analysis

PRU

258.80 ± 34.49

164.60 ± 43.14

3.813

0.005

InhibitionPer

0.20 ± 0.12

0.40 ± 0.17

 − 2.089

0.070

Baseline

326.80 ± 57.50

275.80 ± 41.81

1.604

0.147

Age (year)

63.40 ± 7.92

59.60 ± 8.84

0.715

0.495

Male, n (%)

4 (80)

5 (100)

–

1.000

Hypertension, n (%)

4 (80)

3 (60)

–

1.000

Diabetes, n (%)

0 (0)

1 (20)

–

1.000

Smoking history, n (%)

2 (40)

2 (40)

–

–

Drinking history, n (%)

1 (20)

2 (40)

–

1.000

Statin

1.60 ± 0.55

2.40 ± 0.89

 − 1.706

0.126

PPI

1.00 ± 1.22

0.60 ± 0.55

0.667

0.524

BMI (kg/m²)

23.78 ± 0.87

23.38 ± 2.10

0.393

0.704

Stnet

1.60 ± 0.55

1.00 ± 0.00

2.449

0.070

LVEF (%)

60.60 ± 5.55

61.40 ± 2.51

0.294

0.776

TC (mmol/L)

4.83 ± 1.04

4.80 ± 1.60

0.030

0.977

TG (mmol/L)

1.03 ± 0.50

2.02 ± 0.97

 − 2.025

0.077

HDL (mmol/L)

1.29 ± 0.42

0.95 ± 0.19

1.664

0.135

LDL (mmol/L)

2.76 ± 1.16

2.99 ± 1.42

 − 0.287

0.781

GLU (mmol/L)

5.94 ± 1.73

5.07 ± 0.51

1.078

0.333

HbA1C (%)

5.60 ± 0.53

5.90 ± 0.12

 − 1.225

0.256

ALT (U/L)

31.60 ± 24.58

37.80 ± 32.18

 − 0.342

0.741

AST (U/L)

147.20 ± 179.63

89.8 ± 139.98

0.564

0.588

TBIL (µmol/L)

15.16 ± 8.16

14.54 ± 3.14

0.159

0.878

CREA (µmol/L)

72.91 ± 16.15

69.05 ± 6.77

0.493

0.641

UA (µmmol/L)

408.20 ± 262.48

362.80 ± 60.52

0.370

0.721

hsCRP (mg/L)

3.39 ± 4.63

6.93 ± 11.77

 − 0.626

0.549

PLT (*109/L)

197.60 ± 53.17

218.80 ± 1.15

 − 0.588

0.572

MPV (fL)

7.48 ± 0.72

8.04 ± 1.15

 − 0.922

0.384

PCT (ng/ml)

0.15 ± 0.03

0.18 ± 0.04

 − 1.134

0.290

PDW (fL)

16.28 ± 0.32

16.38 ± 0.71

 − 0.287

0.782